Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CER study of Xueshuantong (lyophilized) for injection in real-world cerebral infarction
ChiCTR2000035062Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of panax notoginseng extract in brain infarction, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Clinical symptoms, Clinical signs and 3 more. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
panax notoginseng extract
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2000035062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035062.